Longevity Health Holdings, Inc. (XAGE)

Market Cap	724.03K -81.2%
Revenue (ttm)	1.79M +220.0%
Net Income	-6.83M
EPS	-4.12
Shares Out	2.48M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,249
Open	0.2925
Previous Close	0.2611
Day's Range	0.2925 - 0.3239
52-Week Range	0.2296 - 8.2700
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Longevity Health Holdings

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The company also develops a microemulsion formula...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2008
• Employees: 10
• Stock Exchange: OTCMKTS
• Ticker Symbol: XAGE

Financial Performance

In 2025, Longevity Health Holdings's revenue was $1.91 million, an increase of 3701.44% compared to the previous year's $50,318. Losses were -$6.91 million, -33.40% less than in 2024.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 20, 2026

Data Sources Report a data error